glp-1 cardiovascular outcomes trial august 2025 Effects and Tolerability of Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients Cardiovascular outcome studies with GLP-1

Verschoor CP, Johnstone J, Millar J, Dorrington MG, Habibagahi M, Lelic A, Loeb M, Bramson JL, Bowdish DM

Preliminary results from the clinical trial that Christina joined, termed the Remain-1 study, indicate that the procedure is working as intended to stabilize weight after GLP-1 therapy

By using GHK-Cu as a single, well-characterized entity, researchers can evaluate both localized and systemic effects of copper peptide signaling without the confounding variability of mixed or poorly defined copper complexes

Your body needs protein to protect your muscles, support your metabolism, and help you feel your best

[DOI] [PMC free article] [PubMed] [Google Scholar] 52.Dallmann A., Liu X.I., Burckart G.J., van den Anker J